![]() |
|
|
UCLA Center for Human Nutrition, David Geffen School of Medicine, University of CaliforniaLos Angeles, Los Angeles, CA 90095-1742
2To whom correspondence should be addressed. E-mail: dheber{at}mednet.ucla.edu.
KEY WORDS: phytochemicals cancer prevention lycopene
| EXPANDED ABSTRACT |
|---|
|
|
|---|
Current National Cancer Institute dietary recommendations emphasize increasing the daily consumption of fruits and vegetables from diverse sources such as citrus fruits, cruciferous vegetables, and green and yellow vegetables (2). Often in the scientific and lay press, a single phytochemical, such as lycopene from tomatoes, is featured for its antioxidant activities when the beneficial effects actually result from the ingestion of foods that contain families of compounds, including, in the case of tomatoes, lycopene, phytoene, phytofluene, vitamin E, and vitamin C. Tomato products, including soups, juices, pasta, and catsup, have received increased attention since Giovanucci and colleagues (3) reported that an increased dietary intake of lycopene is associated with a reduced risk of prostate cancer. Nonetheless, studies of lycopene exemplify the phytochemical functions beyond antioxidation manifested by many phytochemicals.
Lycopene has the highest antioxidant activity among all dietary carotenoids and is very efficient at quenching singlet oxygen and scavenging free radicals (4). Although the antioxidant activity of lycopene, as assayed by inhibition of formation of thiobarbituric acidreactive substances in laboratory studies of multilamellar liposomes (5), is ranked as lycopene >
-tocopherol >
-carotene > ß-cryptoxanthin > zeaxanthin = ß-carotene > lutein, mixtures of carotenoids are more effective than the single compounds. This synergistic effect is most pronounced when lycopene or lutein is present. The superior protection of mixtures may be related to specific positioning of different carotenoids in membranes.
Although lycopene is a carotenoid without provitamin A activity, it has potent effects on prostate cancer cell proliferation alone and in combination with
-tocopherol. Studies of the effects of lycopene and
-tocopherol (vitamin E) on the growth of 2 different human prostate carcinoma cell lines (the androgen-insensitive DU-145 and PC-3) found that lycopene alone is not a potent inhibitor of prostate carcinoma cell proliferation. However, the simultaneous addition of lycopene and
-tocopherol at physiological concentrations (<1 and 50 µmol/L, respectively) strongly inhibits prostate carcinoma cell proliferation, reaching values close to 90% (6). The effect of lycopene with
-tocopherol is synergistic and is not shared by ß-tocopherol, ascorbic acid, and probucol. Furthermore, the combination of low concentrations of lycopene with 1,25-dihydroxyvitamin D3 synergistically inhibits cell proliferation and stimulates differentiation in the HL-60 promyelocytic leukemia cell line (7). Lycopene treatment induces a concentration-dependent reduction in HL-60 cell growth as measured by [3H]thymidine incorporation and cell counting. This effect is accompanied by inhibition of cell cycle progression in the G0/G1 phase as measured by flow cytometry. Lycopene alone induces cell differentiation as measured by phorbol esterdependent reduction of nitro blue tetrazolium and expression of the cell surface antigen CD14. Additional gene-nutrient interactions also may be involved in the observed effects of carotenoids. Studies using human and animal cells have identified a gene, connexin 43, whose expression is upregulated by chemopreventive carotenoids and which allows direct intercellular gap junctional communication (GJC). GJC is deficient in many human tumors, and its restoration or upregulation is associated with decreased proliferation (8).
It is feasible to study the effects of mixtures of phytochemicals on serum biomarkers as demonstrated by a recent clinical trial (9) in which a mixed intake of fruits and vegetables (500 g/d meeting "5-a-day" guidelines vs. 100 g/d) increased folate by 15% and decreased plasma homocysteine by 11% in 47 normal volunteers. The fruit- and vegetable-rich diet provided 13.3 mg carotenoids, 173 mg vitamin C, and 228 µg folate compared to 2.9 mg carotenoids, 65 mg vitamin C, and 131 µg folate. Remarkably, plasma nutritional biomarkers increased by 46% for lutein, 45% for ß-carotene, 64% for vitamin C, and 121% for
-carotene, demonstrating the ability to track such an intervention for cancer prevention.
The key research questions that need to be determined are: a) Can biomarkers of these phytochemical effects be used to follow changes in cancer cell progression, morphology, or biochemistry useful in cancer prevention studies? b) Can methods be developed to simultaneously track the disposition of phytochemicals from fruits and vegetables, given the differences in volumes of distribution, pharmacokinetics of absorption, and the various pathways of metabolism and clearance of these substances? and c) Can synergistic interactions of phytochemicals from fruits and vegetables be demonstrated in vitro and in vivo that provide the scientific substantiation for the popular recommendation (10) to eat a variety of colorful fruits and vegetables for their cancer preventive benefits?
| FOOTNOTES |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
1. Steinmetz, K. A. & Potter, J. D. (1991) Vegetables, fruits, and cancer. I. Epidemiology. Cancer Causes Control 2:325-337.[Medline]
2. Block, G., Patterson, B. & Subar, A. (1992) Fruit, vegetables, and cancer prevention. A review of the epidemiological evidence. Nutr. Cancer 18:1-29.[Medline]
3. Giovanucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A. & Willett, V. C. (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87:1767-1776.
4. Di Mascio, P., Kaiser, S. & Sies, H. (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274:532-538.[Medline]
5. Stahl, W., Junghans, A., de Boer, B., Driomina, E. S., Briviba, K. & Sies, H. (1998) Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 427:305-308.[Medline]
6. Amir, H., Karas, M., Giat, J., Danilenko, M., Levy, R., Yermiahu, T., Levy, J. & Sharoni, Y. (1999) Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer 33:105-112.[Medline]
7. Karas, M., Amir, H., Fishman, D., Danilenko, M., Segal, S., Nahum, A., Koifmann, A., Giat, Y. & Levy, J., et al (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer 36:101-111.[Medline]
8. Stahl, W., von Laar, J., Martin, H. D., Emmerich, T. & Sies, H. (2000) Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys. 373:271-274.[Medline]
9. Broekmans, W. M., Klopping-Ketelaars, I. A., Schuurman, C. R., Verhagen, H., van den Berg, H., Kok, F. J. & van Poppel, G. (2000) Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J. Nutr. 130:1578-1583.
10. Heber, D. & Bowerman, S. (2001) What Color Is Your Diet? 2001 Harper-Collins/Regan Books New York, NY.
This article has been cited by other articles:
![]() |
J. Limpens, F. H. Schroder, C. M. A. de Ridder, C. A. Bolder, M. F. Wildhagen, U. C. Obermuller-Jevic, K. Kramer, and W. M. van Weerden Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice J. Nutr., May 1, 2006; 136(5): 1287 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Seifried, D. E. Anderson, B. C. Sorkin, and R. B. Costello Executive Summary Report J. Nutr., November 1, 2004; 134(11): 3143S - 3163S. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||